Annual Accounts Payable
$3.27 M
+$1.04 M+46.63%
December 31, 2023
Summary
- As of February 7, 2025, PSTX annual accounts payable is $3.27 million, with the most recent change of +$1.04 million (+46.63%) on December 31, 2023.
- During the last 3 years, PSTX annual accounts payable has risen by +$2.50 million (+328.18%).
Performance
PSTX Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Quarterly Accounts Payable
$5.20 M
+$2.21 M+73.81%
September 30, 2024
Summary
- As of February 7, 2025, PSTX quarterly accounts payable is $5.20 million, with the most recent change of +$2.21 million (+73.81%) on September 30, 2024.
- Over the past year, PSTX quarterly accounts payable has increased by +$2.21 million (+73.81%).
Performance
PSTX Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
PSTX Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +46.6% | +73.8% |
| 3 y3 years | +328.2% | +42.6% |
| 5 y5 years | +14.4% | - |
PSTX Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -63.5% | -31.8% | -42.0% | -59.6% |
| 5 y | 5-year | -63.5% | -76.6% | -42.0% | -85.3% |
| alltime | all time | -63.5% | -76.6% | -42.0% | -85.3% |
Poseida Therapeutics Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $5.20 M(+73.8%) |
| Jun 2024 | - | $2.99 M(+10.6%) |
| Mar 2024 | - | $2.70 M(-17.2%) |
| Dec 2023 | $3.27 M(+46.6%) | $3.27 M(+28.5%) |
| Sep 2023 | - | $2.54 M(+21.2%) |
| Jun 2023 | - | $2.10 M(-34.5%) |
| Mar 2023 | - | $3.20 M(+43.6%) |
| Dec 2022 | $2.23 M(-75.1%) | $2.23 M(-35.0%) |
| Sep 2022 | - | $3.43 M(-6.4%) |
| Jun 2022 | - | $3.66 M(+2.0%) |
| Mar 2022 | - | $3.59 M(-59.9%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $8.96 M(+1074.4%) | $8.96 M(+145.9%) |
| Sep 2021 | - | $3.64 M(-19.1%) |
| Jun 2021 | - | $4.51 M(+81.2%) |
| Mar 2021 | - | $2.49 M(+226.0%) |
| Dec 2020 | $763.00 K(-84.5%) | $763.00 K(-39.3%) |
| Sep 2020 | - | $1.26 M(-19.6%) |
| Jun 2020 | - | $1.56 M(-79.7%) |
| Mar 2020 | - | $7.70 M(+56.3%) |
| Dec 2019 | $4.93 M(+72.6%) | $4.93 M |
| Dec 2018 | $2.86 M(+145.4%) | - |
| Dec 2017 | $1.16 M | - |
FAQ
- What is Poseida Therapeutics annual accounts payable?
- What is the all time high annual accounts payable for Poseida Therapeutics?
- What is Poseida Therapeutics annual accounts payable year-on-year change?
- What is Poseida Therapeutics quarterly accounts payable?
- What is the all time high quarterly accounts payable for Poseida Therapeutics?
- What is Poseida Therapeutics quarterly accounts payable year-on-year change?
What is Poseida Therapeutics annual accounts payable?
The current annual accounts payable of PSTX is $3.27 M
What is the all time high annual accounts payable for Poseida Therapeutics?
Poseida Therapeutics all-time high annual accounts payable is $8.96 M
What is Poseida Therapeutics annual accounts payable year-on-year change?
Over the past year, PSTX annual accounts payable has changed by +$1.04 M (+46.63%)
What is Poseida Therapeutics quarterly accounts payable?
The current quarterly accounts payable of PSTX is $5.20 M
What is the all time high quarterly accounts payable for Poseida Therapeutics?
Poseida Therapeutics all-time high quarterly accounts payable is $8.96 M
What is Poseida Therapeutics quarterly accounts payable year-on-year change?
Over the past year, PSTX quarterly accounts payable has changed by +$2.21 M (+73.81%)